Also found in: Wikipedia.

timolol maleate

Apo-Timol, Betim (UK), Betimol, Dom-Timolol, Gen-Timolol, Istalol, Novo-Timol, NU-Timolol, PMS-Timolol, Rhoxal-Timolol, Sandoz Timolol, Timoptic, Timoptix-XE

Pharmacologic class: Beta-adrenergic blocker (nonselective)

Therapeutic class: Antihypertensive, vascular headache suppressant, antiglaucoma agent

Pregnancy risk category C

FDA Box Warning

Exacerbations of angina pectoris and myocardial infarction (MI) may follow abrupt withdrawal of some beta blockers. When discontinuing long-term therapy, particularly in patients with ischemic heart disease, reduce dosage gradually over 1 to 2 weeks and monitor patient carefully. If angina worsens markedly or acute coronary insufficiency develops, reinstate drug promptly (at least temporarily) and take other appropriate measures to manage unstable angina. Caution patient not to interrupt or discontinue therapy without prescriber's advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue drug abruptly even in patients treated only for hypertension.


Blocks stimulation of beta1-adrenergic (myocardial) and beta2-adrenergic (pulmonary, vascular, uterine) receptor sites. May reduce aqueous production, which decreases intraocular pressure (IOP).


Ophthalmic gel: 0.25%, 0.5%

Ophthalmic solution: 0.25%, 0.5%

Tablets: 5 mg, 10 mg, 20 mg

Indications and dosages


Adults: Initially, 10 mg P.O. b.i.d., given alone or with a diuretic; may increase at 7-day intervals as needed. Usual maintenance dosage is 10 to 20 mg daily in two divided doses, up to 60 mg/day.

Acute MI

Adults: 10 mg P.O. b.i.d. starting 1 to 4 weeks after MI

To prevent vascular headaches

Adults: Initially, 10 mg P.O. b.i.d. For maintenance, 20 mg may be given as a single daily dose. Total daily dosage may be increased to a maximum of 30 mg in divided doses or decreased to 10 mg/day, depending on response and tolerance. Withdraw drug if satisfactory response doesn't occur after 6 to 8 weeks at maximum dosage.

Elevated IOP in patients with ocular hypertension or open-angle glaucoma

Adults: One drop of 0.25% to 0.5% ophthalmic solution in affected eye b.i.d., or 0.25% to 0.5% ophthalmic gel in affected eye once daily

Off-label uses

• Angina pectoris
• Supraventricular arrhythmias


• Hypersensitivity to drug or other beta-adrenergic blockers
• Uncompensated heart failure
• Bradycardia or heart block
• Cardiogenic shock
• Bronchial asthma (current or previous), severe chronic obstructive pulmonary disease


Use cautiously in:
• renal or hepatic impairment, diabetes mellitus, thyrotoxicosis
• elderly patients
• pregnant or breastfeeding patients
• children (safety not established).


• Measure apical pulse before giving. If patient has significant bradycardia or tachycardia, withhold dose and consult prescriber.

Adverse reactions

CNS: fatigue, dizziness, asthenia, insomnia, headache, vertigo, nervousness, depression, paresthesia, hallucinations, memory loss, disorientation, emotional lability, clouded sensorium

CV: hypotension, angina pectoris exacerbation, bradycardia, atrioventricular or sinoatrial block, arrhythmias, heart failure

EENT: visual disturbances, dry eyes, tinnitus, nasal congestion

GI: nausea, constipation, diarrhea, abdominal discomfort

GU: erectile dysfunction, decreased libido

Metabolic: hyperuricemia, hypoglycemia, hyperkalemia

Musculoskeletal: joint pain

Respiratory: dyspnea, crackles, bronchospasm, pulmonary edema

Skin: itching, rash


Drug-drug. Antihypertensives, nitrates: additive hypotension

Insulin, oral hypoglycemics: altered efficacy of these drugs

Nonsteroidal anti-inflammatory drugs: decreased antihypertensive effect of timolol

Quinidine: inhibited timolol metabolism, leading to increased beta-adrenergic blockade and bradycardia

Reserpine: increased risk of hypotension and bradycardia

Theophylline: reduced effects of both drugs

Drug-diagnostic tests. Antinuclear antibodies: increased titer

Blood urea nitrogen, liver function tests, potassium, uric acid: increased values

Glucose, high-density lipoproteins, hematocrit, hemoglobin: decreased values

Drug-herbs. Ephedra (ma huang), St. John's wort, yohimbine: decreased timolol efficacy

Patient monitoring

• Closely monitor vital signs, blood pressure, cardiovascular status, and ECG.
• Assess respiratory status. Check breath sounds for wheezing and bronchospasm.
• Monitor blood glucose level in patient with diabetes mellitus.

Patient teaching

• Teach patient how to measure pulse before each dose. Instruct him to contact prescriber if pulse is outside established safe range.

Caution patient not to stop taking drug abruptly. Dosage must be tapered.
• Teach patient how to administer eye drops. Instruct him to use drops only as prescribed, because they are absorbed systemically. Caution him not to touch dropper tip to eye or any other surface.

Teach patient to recognize and immediately report significant adverse respiratory, cardiac, and neurologic reactions.
• Inform patient that many over-the-counter drugs and herbs may decrease the efficacy of timolol. Advise him to consult prescriber before using these products.
• Advise diabetic patient that drug may lower blood glucose level. Encourage regular blood glucose monitoring.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and herbs mentioned above.


A brand name for TIMOLOL.
References in periodicals archive ?
In 1998, Valeo closed down its lighting plant at Minas Gerais, Betim, Brazil and also sold its share in Ergom, a manufacturer of piping for fuel tanks.
987 m(2)) building on 7 acres (3 hectares) in Betim, Brazil, just 27 miles west of Belo Horizonte.
The seats will be assembled in Lear's 80,000 square foot Just-In-Time (JIT) facility in Betim, close to Belo Horizonte.
The Betim plant employs approximately 18,000 workers, who build Tempra and Uno passenger cars and Fiorno vans and pickup trucks.
SGS Laboratories of Betim, Minas Gerais are providing independent sample preparation and assay services, using standard industry practices.
The milestone car was produced at the automaker's Betim plant.
These operations consist of plants in Itabirito and Betim, Brazil, and Buenos Aires, Argentina.
The new vehicle is produced in Brazil with styling direction from the Fiat Design Centre at the Betim plant.
The model is to be produced at the company's Betim plant in Brazil.
Metalurgica Caterina operates two manufacturing facilities near Sao Paulo and one in Betim, in central Brazil.
Delphi Automotive Systems (NYSE: DPH) announced today the immediate closing of its Packard Electric Division's facility in Betim, Minas Gerais.
The automaker's plant in Betim, Brazil is stopping a shift of one production line for a week for maintenance and to balance its product mix.